373 results on '"J. Hitchcock"'
Search Results
152. Development of inducible shRNA cell models for toxicology screening
153. TOPICAL MICROBICIDES
154. CONTRIBUTORS
155. Quantification of Tumor Volume Aliasing on Helical CT Scans for Lung Stereotactic Body Radiation Therapy (SBRT) Patients
156. Preoperative Radiotherapy Improves Overall Survival in General Soft-tissue Sarcoma: Multi-institutional Analysis of 3,163 Patients
157. IMRT with Simultaneous Integrated Boost (IMRT-SIB) Radiotherapy and Concurrent Cisplatin for Locoregional Advanced Squamous Cell Carcinoma of Head and Neck
158. Sexually Transmitted Diseases in the AIDS Era
159. Comparison of Lung-lesion ITVs Generated by 4 Manual/Automated Segmentation Methods
160. Alveolar Soft Part Sarcoma Demographic, Clinical, and Pathologic Predictors of Survival From the Surveillance, Epidemiology, and End Results (SEER) Database
161. Effect of oral probenecid coadministration on the chronic toxicity and pharmacokinetics of intravenous cidofovir in cynomolgus monkeys
162. Catastrophic transcatheter baffle fenestration for failing Fontan physiology
163. Analyses of the immunoaccessibility of H8 antigen and the functionality of H8 specific monoclonal antibody 10
164. [Untitled]
165. [Untitled]
166. Epidemiology of post-neonatal bacterial meningitis in Cape Town children
167. Paediatric and adolescent gynaecology: a multidisciplinary approach
168. Significant Reduction of Radiation Related Morbidities in the Extremity Sarcoma Patients Treated With Image Guided Radiation Therapy to Reduced Target Volume: Results of RTOG 0630
169. Pharmacokinetics of cidofovir in monkeys. Evidence for a prolonged elimination phase representing phosphorylated drug
170. Women, children and STDs: addressing the other STD epidemic. Opinion
171. Adolescents and sexually transmitted diseases
172. A preclinical and clinical overview of the nucleotide-based antiviral agent cidofovir (HPMPC)
173. A Unique Geographical Analysis of Lung Cancer Patients in the State of Utah
174. Population Monitoring and Status of the California Red-Legged Frog (Rana aurora draytonii) and Unarmored Threespine Stickleback (Gasterosteus aculeatus williamsoni) in the Angeles National Forest, 2003
175. Prodrugs of 2',3'-didehydro-3'-deoxythymidine (D4T): synthesis, antiviral activity, and rapid pharmacokinetic evaluation
176. Carriage of Haemophilus influenzae in Cape Town children
177. Epidemiology of invasive Haemophilus influenzae infections in Cape Town, South Africa
178. Using Information to Change Sexually Transmitted Disease-Related Behaviors
179. CT On-Rails (CTOR) Characterization of Tumor Volume Rate-of-Reduction in Head Neck Squamous Cell Carcinoma Treated with IMRT Simultaneous Integrated Boost (IMRT-SIB) and Concurrent Chemotherapy
180. WE-E-BRC-06: Comparison of Two Methods of Contouring Internal Target Volume on Multiple 4DCT Data Sets from the Same Subjects: Maximum Intensity Projection and Combination of 10 Phases
181. Aneurysmal pericardial patch producing right ventricular inflow obstruction
182. Quantitative study of the development and maturation of human oesophageal innervation
183. Cellular metabolism and enzymatic phosphorylation of 9-(2-phosphonylmethoxyethyl) guanine (PMEG), a potent antiviral agent
184. Intracellular metabolism of the antiherpes agent (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine
185. A Preliminary Report: Dynamic Contrast-enhanced Magnetic Resonance (DCE-MRI) for Assessing Intratumoral Microvascular Changes in Patients with High-grade Soft Tissue Sarcoma, Treated with Preoperative Radiotherapy
186. Quantification of a Baseline Shift of Tumor Motion Envelope for Stereotactic Body Radiation Therapy (SBRT) of Lung
187. Metabolism and DNA interaction of 2',3'-didehydro-2',3'-dideoxythymidine in human bone marrow cells
188. Phosphonomethylether compounds as antiviral agents
189. SU-GG-T-102: Evaluation of Smoothing/Complexity Adjustment Feature for Three IMRT Inverse Treatment Planning Systems
190. Report of the NIAID Study Group on Integrated Behavioral Research for Prevention and Control of Sexually Transmitted Diseases. Part I: Issues in defining behavioral risk factors and their distribution
191. (S)-1-(3-hydroxy-2-(phosphonylmethoxy)propyl)cytosine (HPMPC): a potent antiherpesvirus agent
192. An Overview of Mitochondrial Toxicity of Nucleoside Reverse Transcriptase Inhibitors Associated with HIV Therapy
193. Optimization of IMRT Fluence-Map Smoothing can Result in Improved IMRT Plans
194. [Untitled]
195. PREFACE
196. Improving Performance of HVAC Systems to Reduce Exposure to Aerosolized Infectious Agents in Buildings; Recommendations to Reduce Risks Posed by Biological Attacks.
197. Ectomycorrhizal mycobionts of Pisonia grandis on coral cays in the Capricorn-Bunker group, Great Barrier Reef, Australia.
198. Development of markers for simple sequence repeat-rich regions that discriminate between Pisolithus albus and P. microcarpus.
199. Preface
200. Interaction of Neisseria gonorrhoeae with classical complement components, C1-inhibitor, and a monoclonal antibody directed against the Neisserial H.8 antigen
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.